Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Board Appointment

7 Feb 2017 07:00

RNS Number : 1689W
BrainJuicer Group PLC
07 February 2017
 

 

 

 

 

Press Release

7 February 2017

 

BrainJuicer Group PLC (AIM: BJU)

("BrainJuicer" or "the Company")

 

 

Board appointment

 

 

BrainJuicer announces that it has promoted Alex Hunt, who has headed its successful business in the Americas since 2015, to run its market research business worldwide. With effect from 1st April 2017, Alex will join BrainJuicer's Board of Directors, where he will join the three current executive directors, CEO John Kearon, CFO James Geddes, and COO Alex Batchelor, and the three non-executive directors, Ken Ford (Chairman), Robert Brand and Graham Blashill.

 

Alex, who is 35, has over 15 years of marketing experience and a proven track record of helping clients grow famous brands and develop award winning and effective communications. He began his career with Millward Brown, part of the WPP group, where he worked with a range of large consumer products, media, financial and retail clients in the UK and US. Alex joined BrainJuicer in 2009, and became co-head of its US business in 2012. Alex is a regular speaker at marketing and insights industry events as well as at several US business schools.

 

Commenting on the announcement, John Kearon said: "Alex is a phenomenal leader and has built a great team and successful business in the US and Latin America. Alex's leadership of the market research business globally is an exciting part of our plans for the company's next phase of ambitious growth. We're delighted to welcome Alex to the Board and look forward to achieving great things together in the coming years."

 

Alexander James Hunt holds no shares in the Company, and there are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

 

 

For further information, please contact:

BrainJuicer Group PLC

 +44 (0)20 7043 1000

John Kearon, Chief Executive Officer

James Geddes, Chief Financial Officer

Canaccord Genuity Limited (Nomad & Broker)

+44 (0)20 7523 8000

Simon Bridges / Emma Gabriel

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFLAFEIRIID
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.